Côd QR

Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction

Summary: The mitochondrial dysfunction characteristic of heart failure (HF) is associated with changes in intracellular nicotinamide adenine dinucleotide (NAD+) and NADH levels. Raising NAD+ levels with the NAD+ precursor, nicotinamide riboside (NR), may represent a novel HF treatment. In this 30-pa...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Dennis D. Wang, MD, PhD, Sophia E. Airhart, MD, Bo Zhou, PhD, Laura M. Shireman, PhD, Siyi Jiang, BS, Carolina Melendez Rodriguez, MD, James N. Kirkpatrick, MD, Danny D. Shen, PhD, Rong Tian, MD, PhD, Kevin D. O’Brien, MD
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2022-12-01
Cyfres:JACC: Basic to Translational Science
Pynciau:
nicotinamide riboside
NR
nicotinamide adenine dinucleotide
NAD+
heart failure with reduced ejection fraction
HFrEF
Mynediad Ar-lein:http://www.sciencedirect.com/science/article/pii/S2452302X22002327
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg